Patents by Inventor Sandra Hubner

Sandra Hubner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11053200
    Abstract: A method for producing a radiofluorinated compound having an aromatic or heteroaromatic ring carrying [18F] fluorine as first substituent, a bonding unit, which can bind to a peptide or peptide mimetic, and a spacer group connected via bond A1 to the bonding unit and via bond A2 to the ring, wherein the bonding unit has second substituent(s) —OH, —CONH, and/or —COOH. The steps include (a) providing a precursor having the ring carrying a substituent Y, bonding unit with the second substituent(s), and spacer group, wherein substituent Y is —N+(R1R2R3), —NO2, —Cl, —Br, —F, or —I, and R1, R2, and R3 are independently C1-C6 alkyl; and (b) reacting the precursor with a [18F] fluoride anion in the presence of an activation salt to the radiofluorinated compound, which has a cation N+(R4R5R6R7) with R4, R5, R6, and R7 being independently C1-C6 alkyl, wherein the substituent Y is replaced by [18F] fluoride.
    Type: Grant
    Filed: January 31, 2020
    Date of Patent: July 6, 2021
    Assignee: ABX advanced biochemical compounds GmbH
    Inventors: René Martin, René Smits, Ronny Hesse, Alexander Hoepping, Marco Müller, Sandra Hübner
  • Patent number: 10759760
    Abstract: A method for producing a radiofluorinated compound having an aromatic or heteroaromatic ring carrying [18F] fluorine as first substituent, a bonding unit, which can bind to a peptide or peptide mimetic, and a spacer group connected via bond A1 to the bonding unit and via bond A2 to the ring, wherein the bonding unit has second substituent(s) —OH, —CONH, and/or —COOH. The steps include (a) providing a precursor having the ring carrying a substituent Y, bonding unit with the second substituent(s), and spacer group, wherein substituent Y is —N+(R1R2R3), —NO2, —Cl, —Br, —F, or —I, and R1, R2, and R3 are independently C1-C6 alkyl; and (b) reacting the precursor with a [18F] fluoride anion in the presence of an activation salt to the radiofluorinated compound, which has a cation N+(R4R5R6R7) with R4, R5, R6, and R7 being independently C1-C6 alkyl, wherein the substituent Y is replaced by [18F] fluoride.
    Type: Grant
    Filed: November 17, 2017
    Date of Patent: September 1, 2020
    Assignee: ABX ADVANCED BIOCHEMICAL COMPOUNDS GMBH
    Inventors: René Martin, René Smits, Ronny Hesse, Alexander Hoepping, Marco Müller, Sandra Hübner
  • Publication number: 20200165204
    Abstract: A method for producing a radiofluorinated compound having an aromatic or heteroaromatic ring carrying [18F] fluorine as first substituent, a bonding unit, which can bind to a peptide or peptide mimetic, and a spacer group connected via bond A1 to the bonding unit and via bond A2 to the ring, wherein the bonding unit has second substituent(s) —OH, —CONH, and/or —COOH. The steps include (a) providing a precursor having the ring carrying a substituent Y, bonding unit with the second substituent(s), and spacer group, wherein substituent Y is —N+(R1R2R3), —NO2, —Cl, —Br, —F, or —I, and R1, R2, and R3 are independently C1-C6 alkyl; and (b) reacting the precursor with a [18F] fluoride anion in the presence of an activation salt to the radiofluorinated compound, which has a cation N+(R4R5R6R7) with R4, R5, R6, and R7 being independently C1-C6 alkyl, wherein the substituent Y is replaced by [18F] fluoride.
    Type: Application
    Filed: January 31, 2020
    Publication date: May 28, 2020
    Applicant: ABX advanced biochemical compounds GmbH
    Inventors: René MARTIN, René SMITS, Ronny HESSE, Alexander HOEPPING, Marco MÜLLER, Sandra HÜBNER
  • Publication number: 20190300462
    Abstract: The present invention relates to a selective reduction of specific aldehydes and ketones to their corresponding alcohols.
    Type: Application
    Filed: May 11, 2017
    Publication date: October 3, 2019
    Inventors: Matthias BELLER, Werner BONRATH, Johannes Gerardus DE VRIES, Yuting FAN, Sandra HÜBNER, Laurent LEFORT, Jonathan Alan MEDLOCK, Pim PUYLAERT, Richard VAN HECK
  • Publication number: 20190263756
    Abstract: A method for producing a radiofluorinated compound having an aromatic or heteroaromatic ring carrying [18F] fluorine as first substituent, a bonding unit, which can bind to a peptide or peptide mimetic, and a spacer group connected via bond A1 to the bonding unit and via bond A2 to the ring, wherein the bonding unit has second substituent(s) —OH, —CONH, and/or —COOH. The steps include (a) providing a precursor having the ring carrying a substituent Y, bonding unit with the second substituent(s), and spacer group, wherein substituent Y is —N+(R1R2R3), —NO2, —Cl, —Br, —F, or —I, and R1, R2, and R3 are independently C1-C6 alkyl; and (b) reacting the precursor with a [18F] fluoride anion in the presence of an activation salt to the radiofluorinated compound, which has a cation N+(R4R5R6R7) with R4, R5, R6, and R7 being independently C1-C6 alkyl, wherein the substituent Y is replaced by [18F] fluoride.
    Type: Application
    Filed: November 17, 2017
    Publication date: August 29, 2019
    Applicant: ABX ADVANCED BIOCHEMICAL COMPOUNDS GMBH
    Inventors: René MARTIN, René SMITS, Ronny HESSE, Alexander HOEPPING, Marco MÜLLER, Sandra HÜBNER
  • Publication number: 20190144365
    Abstract: The present invention relates to a selective reduction of esters to their corresponding alcohols.
    Type: Application
    Filed: May 11, 2017
    Publication date: May 16, 2019
    Inventors: Matthias BELLER, Werner BONRATH, Johannes Gerardus DE VRIES, Yuting FAN, Sandra HÜBNER, Laurent LEFORT, Jonathan Alan MEDLOCK, Pim PUYLAERT, Richard VAN HECK
  • Patent number: 9718965
    Abstract: The present invention relates to platelet-shaped zinc-magnesium pigments, wherein the platelet-shaped zinc-magnesium pigments comprise the 40.8 to 67.8 mol % of zinc, 32.2 to 59.2 mol % of magnesium and 0 to 7 mol % of Mn, Li, Be, Y, Sn, Al, Ti, Fe, Cu and mixtures thereof, based in each case on the total molar amount of the elements Zn, Mg, Mn, Be, Y, Li, Sn, Al, Ti, Fe and Cu, where the molar percentages add up to 100 mol %, and the median thickness h50 of the pigments is less than 1 ?m. The invention further relates to the use and production of these pigments.
    Type: Grant
    Filed: August 20, 2013
    Date of Patent: August 1, 2017
    Assignee: ECKART GMBH
    Inventors: Markus Rupprecht, Christian Wolfrum, Dominik Pfammatter, Sandra Hubner, Laurent Constantin, Guy Decelles, Thomas Voit, Horst Hafner
  • Publication number: 20150218388
    Abstract: The present invention relates to platelet-shaped zinc-magnesium pigments, wherein the platelet-shaped zinc-magnesium pigments comprise the 40.8 to 67.8 mol % of zinc, 32.2 to 59.2 mol % of magnesium and 0 to 7 mol % of Mn, Li, Be, Y, Sn, Al, Ti, Fe, Cu and mixtures thereof, based in each case on the total molar amount of the elements Zn, Mg, Mn, Be, Y, Li, Sn, Al, Ti, Fe and Cu, where the molar percentages add up to 100 mol %, and the median thickness h50 of the pigments is less than 1 ?m. The invention further relates to the use and production of these pigments.
    Type: Application
    Filed: August 20, 2013
    Publication date: August 6, 2015
    Inventors: Markus Rupprecht, Christian Wolfrum, Dominik Pfammatter, Sandra Hubner, Laurent Constantin, Guy Decelles, Thomas Voit, Horst Hafner